Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03159156
Other study ID # MOP-133459
Secondary ID
Status Recruiting
Phase N/A
First received May 15, 2017
Last updated May 17, 2017
Start date September 15, 2015
Est. completion date May 31, 2018

Study information

Verified date May 2017
Source McGill University
Contact Blaine Ditto, PhD
Phone 514-398-6097
Email blaine.ditto@mcgill.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For a number of years, researchers have examined the effects of the muscle-tensing technique, Applied Tension (AT), on blood donation-related vasovagal symptoms and donor retention. AT was developed originally to reduce symptoms and avoidance behaviour in people with strong fears of blood and needles (phobics). It was based on the idea that exercise-related increases in blood pressure might be able to counteract the effects of stimuli that lead to a decrease in delivery of blood to the brain. AT was adapted for non-phobic blood donors and significant reductions in self-reported vasovagal symptoms and the need for nurse-initiated treatment as well as increases in donor retention were observed in some groups.

That said, individual response to AT is quite variable. This is probably related to recent research indicating that exercise-related maintenance of heart rate and blood pressure plays only a minor role in reducing vasovagal symptoms. Rather, AT appears to be working at least in part by regulating breathing and reducing the possibility of hyperventilation. Pilot results suggest that a novel intervention aimed specifically at breathing may be more effective and reliable than traditional AT. To evaluate this idea, 408 blood donors at mobile clinics in colleges and universities will be assigned randomly to four conditions. In brief, 5-minute preparation sessions using a notebook computer, donors will either learn a respiration control technique to avoid hyperventilation, AT, both, or neither. As a manipulation check and also a means of examining mechanisms of the interventions, e.g., the possibility that AT may work by regulating breathing and CO2, participants will wear non-invasive portable capnometers while they are giving blood. Outcome will also be assessed by self-report of vasovagal symptoms, observational data, and number of return visits to a blood clinic in the following year verified by the provincial blood collection agency, Héma-Québec. As a secondary aim, the research will examine possible moderating effects of pre-donation anxiety and sex.

The development of simple, effective approaches to reduce vasovagal symptoms during blood donation has the potential to improve the blood donation experience and blood donor retention as well as encourage people who have never given blood to consider the procedure. It will also improve medical and dental care more generally given the use of needles in so many procedures.


Description:

See above.


Recruitment information / eligibility

Status Recruiting
Enrollment 408
Est. completion date May 31, 2018
Est. primary completion date May 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria:

- Healthy volunteer blood donors.

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Applied Tension
Described above.
Respiration Control
Described above.
Applied Tension/Respiration Control
Described above.

Locations

Country Name City State
Canada McGill University Montréal Quebec

Sponsors (2)

Lead Sponsor Collaborator
McGill University Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in End Tidal CO2 assessed by ambulatory monitor (capnometer) change in mean value during the pre-donation waiting period (registration to going to chair, approximately 30 minutes) to the mean value in the donation chair (approximately 15 minutes)
Primary Change in Respiration Rate assessed by ambulatory monitor (capnometer) change in mean value during the pre-donation waiting period (registration to going to chair, approximately 30 minutes) to the mean value in the donation chair (approximately 15 minutes)
Primary Blood Donation Reactions Inventory questionnaire assessing presyncopal vasovagal symptoms completed in the recovery area, approximately 15 minutes after blood donation
Primary Research Assistant Observations participant anxiety, fainting, whether or not treatment for a vasovagal response required, etc., noted by a research assistant during blood donation
Secondary Change in Spielberger State Anxiety Scale Score self-report questionnaire completed just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in anxiety
Secondary Medical Fears Survey self-report questionnaire completed in the recovery area, approximately 15 minutes after blood donation
Secondary Change in Systolic Blood Pressure in mmHg measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in blood pressure
Secondary Change in Diastolic Blood Pressure in mmHg measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in blood pressure
Secondary Change in Heart Rate in bpm measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in heart rate
Secondary Blood Donor Return number of times the donor returns to give blood again in a one-year time frame as reported by Hema-Quebec one year after participating in the study
See also
  Status Clinical Trial Phase
Recruiting NCT05555771 - Paediatric Syncope in the Emergency Department N/A
Completed NCT06038708 - Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
Not yet recruiting NCT05572034 - Cardiac Autonomic Denervation for Cardio-inhibitory Syncope N/A
Completed NCT05729724 - Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
Recruiting NCT04595942 - Midodrine and Fludrocortisone for Vasovagal Syncope Phase 3
Completed NCT03903744 - Cardioneuroablation for Reflex Syncope N/A
Completed NCT05782647 - Wearable Monitor in Patients With Syncope N/A
Completed NCT00465439 - Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal N/A
Active, not recruiting NCT01621464 - Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study) Phase 4
Recruiting NCT06336031 - Impact of Blood Phobia on Fainting Susceptibility N/A
Completed NCT01617616 - Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects N/A
Recruiting NCT05086679 - Compression Stockings for Treating Vasovagal Syncope Trial N/A
Completed NCT04772755 - Presyncope (Syncope) Prevention Study N/A
Completed NCT03533829 - Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study N/A
Completed NCT05782699 - Detecting Syncope by an Integrated Multisensor Patch-type Recorder N/A
Completed NCT01695525 - Influence of Yoga in Patients With Neurocardiogenic Syncope Phase 0
Completed NCT00475462 - The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents N/A
Completed NCT04972123 - The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope Phase 2
Completed NCT00302900 - Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations Phase 2
Completed NCT03717207 - Cardiac Autonomic Dysfunction in Diabetics Patients With Syncope